Cargando…
Non-invasive monitoring of drug action: A new live in vitro assay design for Chagas’ disease drug discovery
New assay designs are needed to improve the predictive value of the Trypanosoma cruzi in vitro tests used as part of the Chagas' disease drug development pipeline. Here, we employed a green fluorescent protein (eGFP)-expressing parasite line and live high-content imaging to monitor the growth o...
Autores principales: | Fesser, Anna F., Braissant, Olivier, Olmo, Francisco, Kelly, John M., Mäser, Pascal, Kaiser, Marcel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419005/ https://www.ncbi.nlm.nih.gov/pubmed/32716934 http://dx.doi.org/10.1371/journal.pntd.0008487 |
Ejemplares similares
-
Trypanosoma cruzi STIB980: A TcI Strain for Drug Discovery and Reverse Genetics
por: Fesser, Anna, et al.
Publicado: (2023) -
Neue Parameter für die Wirkstofftestung gegen Trypanosoma cruzi
por: Fesser, Anna, et al.
Publicado: (2021) -
Challenges in Chagas Disease Drug Development
por: Francisco, Amanda F., et al.
Publicado: (2020) -
Isothermal microcalorimetry – A quantitative method to monitor Trypanosoma congolense growth and growth inhibition by trypanocidal drugs in real time
por: Gysin, M., et al.
Publicado: (2018) -
Live-imaging rate-of-kill compound profiling for Chagas disease drug discovery with a new automated high-content assay
por: Svensen, Nina, et al.
Publicado: (2021)